Orca Biosystems
Orca Biosystems is a United States-based cell therapy company running 2 late-stage cancer trials in myelodysplastic syndromes / neoplasms and acute myeloid leukaemia.
Overview
Orca Biosystems, based in Menlo Park, CA, the United States, is a cell therapy company. Orca Bio is a late-stage biotechnology company developing high-precision, engineered allogeneic cell therapies for cancer and autoimmune diseases. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3) in myelodysplastic syndromes / neoplasms and acute myeloid leukaemia. The largest, NCT05316701 (Precision-T: A Randomised Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Haematologic Malignancies), plans to enrol 187 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyTreadwell Therapeutics
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyRyvu Therapeutics
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyEllipses Pharma
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyOncoVerity
Shares Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyShenzhen TargetRx
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyMiltenyi Biomedicine
Shares Acute myeloid leukaemia and the tag ctgov-sponsor.
- PersonMarc H.G.P. Raaijmakers
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.